Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rohinitib, a potent and specific eIF4A inhibitor, effectively induces apoptosis in acute myeloid leukemia (AML) cell lines and decreases the leukemia burden in AML xenograft models. This compound is utilized in the research of AML.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Rohinitib, a potent and specific eIF4A inhibitor, effectively induces apoptosis in acute myeloid leukemia (AML) cell lines and decreases the leukemia burden in AML xenograft models. This compound is utilized in the research of AML. |
Molecular Weight | 521.56 |
Formula | C29H31NO8 |
CAS No. | 1139253-73-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rohinitib 1139253-73-8 Setileuton MK0633 Tosylate MK 0633 Tosylate MK-0633 Tosylate inhibitor inhibit